Ginemed. Sevilla.
Formación acadméica
- Especialista en Obstetricia y Ginecología.
- Master en Patología mamaria.
Situación profesional actual
- Desde 1996: Codirector de GINEMED.
Proyectos de investigación financiados
MEGASET (Menopur in GnRH Antagonist Cycles with Single Embrio Transfer) Trial FE 999906 CS08 A ransomised, open label, assessor blind, parallel groups, multicentre trial comparing the efficacy of menopur versus recombinant FSH in controlled ovarian stimulation following a GnRH antagonist protocol and single embryo transfer. (EudraCT Number: 2008-006775-67)
IMSIGHT Impacto clínico de la microinyección de espermatozoides morfologícamente seleccionados (IMSI) para inyección intracitoplásmica de esperma (ICSI) en pacientes no seleccionados"
EMR200497-001 Exploratory, non-interventional study to identify and validate biomarkers in follicular fluid, cumulus or granulosa cells or embryo culture media for prediction of implantation and pregnancy outcome of Assisted Reproductive Technology cycle.
ESTHER -1 (Evidence-based Stimulation Trial with Human rFSH in Europe and Rest of World)clinical trial 000004 with title “A randomised, controlled, assessor-blind, parallel groups, multicentre, multinational trial comparing the efficacy and safety of FE 999049 with follitropin alfa (GONAL-F) in controlled ovarian stimulation in women undergoing an assisted reproductive technology programme” (EudraCT number 2013-001669-17 / IND number 103,040).
GENPASE código de protocolo MER-GEN-2013-01 Estudio aleatorizado, abierto y controlado para evaluar el efecto de Genadis sobre los parámetros seminales en sujetos oligo y/o astenozoospérmicos
ESTHER-2 (Evidence-based Stimulation Trial with Human rFSH in Europe and Rest of World). Trial 000071. A controlled, assessor-blind, parallel groups, multicentre, multinational trial evaluating the immunogenicity of FE 999049 in repeated cycles of controlled ovarian stimulation in women undergoing an assisted reproductive technology programme. (EudraCT Number: 2013-001616-30 / IND Number: 103,040).
ESPART A phase III, randomized, controlled, single-blind,multicentre, parallel arm trial to assess the efficacy and safety of Pergoveris® (follitropin alfa and lutropin alfa) and GONAL-f® (follitropin alfa) for multifollicular development as part of an assisted
reproductive technology treatment cycle in poor ovarian responders, as defined by the European Society of Human Reproduction and Embryology criteria (EudraCT Number 2013-003817-16)
“Plataforma Observacional de Test de Reserva Ovárica en mujeres pobre respondedoras (OPORTO RETROSPECTIVO)”. Código de protocolo del promotor: MER-FER-2014-02
OBSEVA “A phase II, double-blind, dose-finding, placebo-controlled study to assess the safety and efficacy of a single oral administration of OBE001 to improve embryo implantation following IVF or ICSI.” Protocol no. 14-OBE001-013
Valoración de la eficacia de SEIDIVID en la mejora de la calidad ovocitaria en el desarrollo multifolicular dentro de un ciclo de tratamiento de reproducción asistida (TRA).
Otras actividades académicas relevantes
- 2014/2015: Profesor asociado Master de Reproducción Asistida Universidad de Sevilla.
